Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staphylococcus and Neisseria Tablets in Uncontrolled Bronchial Asthma
NCT06895460Phase 3Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2025
- Primary completion
- Jun 2027
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of staphylococcus albus + neisseria catarrhalis in asthma, sponsored by Jiangsu Provincial People's Hospital. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
staphylococcus albus + neisseria catarrhalis
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06895460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06895460.